Eugenodilol is an alpha-1 blocker and beta blocker with weak β2-adrenergic receptor agonist activity derived from eugenol.[1]

Eugenodilol
Clinical data
ATC code
  • None
Identifiers
  • 1-(4-Allyl-2-methoxyphenoxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}-2-propanol
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H29NO5
Molar mass387.476 g·mol−1
3D model (JSmol)
  • O(c1ccc(cc1OC)C\C=C)CC(O)CNCCOc2ccccc2OC
  • InChI=1S/C22H29NO5/c1-4-7-17-10-11-21(22(14-17)26-3)28-16-18(24)15-23-12-13-27-20-9-6-5-8-19(20)25-2/h4-6,8-11,14,18,23-24H,1,7,12-13,15-16H2,2-3H3
  • Key:NWFVEPJYORHHOG-UHFFFAOYSA-N

References

edit
  1. ^ Huang YC, Wu BN, Lin YT, Chen SJ, Chiu CC, Cheng CJ, Chen IJ (Jul 1999). "Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities". J Cardiovasc Pharmacol. 34 (1): 10–20. doi:10.1097/00005344-199907000-00003. PMID 10413061.